GNPX

Genprex, Inc. NCM · GNPX

$7.67 -0.33 (-4.12%)

Blow-off · +7.77σ Hot zone Grade B

+ Compare Open in Sniper

Valuation

Market cap $0.0B

P/E (ttm) —

Forward P/E -3.5

Beta (5y) -0.91

Shares out 0.5M

Div yield —

Profitability & returns

ROE -160.8%

Net margin —

FCF margin —

Debt / equity —

Trading information

Last price $7.67

Day range $7.01 – $7.94

52-wk range $0.42 – $9.99

Avg volume 0.0M

RSI (2) 91.7

Trend zone Blow-off

52-week range · today's price

$0.42$9.99

Company

Sector Healthcare

Industry Biotechnology

Exchange NCM

Next earnings —

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-bas…